Insider · CIK 0001712187
Dwight H Egan
Files at CODX (Co-Diagnostics, Inc.). First filing -, latest -.
In brief
Dwight H Egan files SEC Form 4 as CEO and director at CODX (Co-Diagnostics, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Dwight H Egan has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 16 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| May 23, 2026 | CODX Co-Diagnostics, Inc. | AGrant or award Common Stock | +4,584 | $0.00 | $0 | 29,526 | May 27, 2026 |
| May 23, 2026 | CODX Co-Diagnostics, Inc. | DDisposition to issuer Common Stock | -1,633 | $5.07 | $8,279 | 27,893 | May 27, 2026 |
| May 23, 2026 | CODX Co-Diagnostics, Inc. | MOption exercise Restricted Stock Unitderivative | -4,584 | $0.00 | $0 | 9,166 | May 27, 2026 |
| Nov 23, 2025 | CODX Co-Diagnostics, Inc. | AGrant or award Common Stock | +163,333 | $0.00 | $0 | 797,827 | Nov 24, 2025 |
| Nov 23, 2025 | CODX Co-Diagnostics, Inc. | DDisposition to issuer Common Stock | -49,575 | $0.35 | $17k | 748,252 | Nov 24, 2025 |
| Nov 23, 2025 | CODX Co-Diagnostics, Inc. | MOption exercise Restricted Stock Unitderivative | -163,333 | $0.00 | $0 | 412,500 | Nov 24, 2025 |
| Aug 13, 2025 | CODX Co-Diagnostics, Inc. | AGrant or award Restricted Stock Unitsderivative | +275,000 | $0.00 | $0 | 575,833 | Aug 15, 2025 |
| May 23, 2025 | CODX Co-Diagnostics, Inc. | AGrant or award Common Stock | +163,334 | $0.00 | $0 | 686,191 | May 27, 2025 |
| May 23, 2025 | CODX Co-Diagnostics, Inc. | DDisposition to issuer Common Stock | -51,697 | $0.24 | $12k | 634,494 | May 27, 2025 |
| May 23, 2025 | CODX Co-Diagnostics, Inc. | MOption exercise Restricted Stock Unitderivative | -163,334 | $0.00 | $0 | 300,833 | May 27, 2025 |
| Nov 23, 2024 | CODX Co-Diagnostics, Inc. | AGrant or award Common Stock | +163,333 | $0.00 | $0 | 572,547 | Nov 25, 2024 |
| Nov 23, 2024 | CODX Co-Diagnostics, Inc. | DDisposition to issuer Common Stock | -49,689 | $1.01 | $50k | 522,858 | Nov 25, 2024 |
| Nov 23, 2024 | CODX Co-Diagnostics, Inc. | MOption exercise Restricted Stock Unitderivative | -163,333 | $0.00 | $0 | 464,167 | Nov 25, 2024 |
| Nov 23, 2023 | CODX Co-Diagnostics, Inc. | AGrant or award Common Stock | +150,834 | $0.00 | $0 | 316,928 | Nov 27, 2023 |
| Nov 23, 2023 | CODX Co-Diagnostics, Inc. | DDisposition to issuer Common Stock | -46,047 | $1.26 | $58k | 270,881 | Nov 27, 2023 |
| Nov 23, 2023 | CODX Co-Diagnostics, Inc. | MOption exercise Restricted Stock Unitderivative | -150,834 | $0.00 | $0 | 490,833 | Nov 27, 2023 |
Questions about Dwight H Egan
Answered from the filings on this page, as of the latest one.
Is Dwight H Egan buying or selling?
Dwight H Egan has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Dwight H Egan's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Dwight H Egan has 0.
Where does Dwight H Egan file Form 4?
Dwight H Egan has filed Form 4 at CODX (Co-Diagnostics, Inc.) as Chief Executive Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.